Synulox Ready to Use Injection
Synulox Ready to Use Injection
Authorised
- Potassium clavulanate
- Amoxicillin trihydrate
Product identification
Medicine name:
Synulox Ready to Use Injection
Active substance:
- Potassium clavulanate
- Amoxicillin trihydrate
Target species:
-
Cattle
-
Dog
-
Cat
-
Pig
Route of administration:
-
Intramuscular use
-
Subcutaneous use
Product details
Active substance and strength:
-
Potassium clavulanate64.21/milligram(s)1.00millilitre(s)
-
Amoxicillin trihydrate160.70/milligram(s)1.00millilitre(s)
Pharmaceutical form:
-
Suspension for injection
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QJ01CR02
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Ireland
Package description:
- Type III glass vials of 40 ml containing an off-white sterile, non-aqueous suspension. The vials are sealed with a rubber bungand an aluminium seal. Each vial contains a sterile off-white to pale buff coloured, smooth fluid, readily dispersable suspension.
- Type III glass vials of 100 ml containing an off-white sterile, non-aqueous suspension. The vials are sealed with a rubber bungand an aluminium seal. Each vial contains a sterile off-white to pale buff coloured, smooth fluid, readily dispersable suspension.
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Zoetis Belgium S.A.
Marketing authorisation date:
Manufacturing sites for batch release:
- Haupt Pharma Latina S.r.l.
Responsible authority:
- Health Products Regulatory Authority
Authorisation number:
- VPA10387/075/001
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
English (PDF)
Download Published on: 27/04/2025